Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Please check this thinking

Please check this thinking

posted on Jan 21, 2008 08:26PM

If the financial and or other terms of the settlements were NOT material events, why would PTSC or other insiders of the deal be prohibited from trading in PTSC. Afterall, no license deals to date has had the terms disclosed until the following 10q, yet PTSC insiders have been able to trade before those terms were revealed.

Does this not mean that the financial aspects of this deal ARE material, and that is the reason why no trading can take place until they can be released. Afterall, we know ABOUT the settlements, we just don't know how the financial terms are structured. It seems that those financial terms HAVE to be material, as that's the only thing that makes them different from previous license deals, isn't it?

For the deals to be material, doesn't that reflect substantial monies involved. What would be the threshhold for these deals to be considered material? Does anyone know definitively that minimum amount? When I think of it this way, it seems clear. What am I missing?

Share
New Message
Please login to post a reply